Cancer research has come a long way over the past few decades. Tailored therapies, understanding lifestyle factors and insight into how tumors work on a molecular level, among other areas of research, have led to an overall decrease in the rate of cancer deaths.
Levine Cancer Institute’s world-renowned physicians are at the forefront of cancer research. Physicians specializing in many different fields are making breakthroughs that reverberate not only across the Carolinas, but across the world.
Clinical trials are research studies designed to answer questions about new ways to diagnose, treat and prevent cancer. Clinical trial participants have the opportunity to receive new research treatments before they are widely available and help others by contributing to medical research. Trials are essential to develop new treatments for cancer.
Our Oncology Clinical Trials Program offers patients a wide range of trials that benefit those undergoing initial cancer treatments, those who have recurring or advanced cancer, and those who have common or rare cancers. Studies are conducted by the highly skilled team of Levine Cancer Institute oncologists, who specialize in breast, gynecologic, prostate, lung, colorectal and other types of cancer, and are leaders in the field of cancer research. Our cancer experts have had the privilege of conducting trials to evaluate various cancer treatments approved for use by the FDA.
Levine Cancer Institute's research and administrative headquarters was designed with a specialized Phase 1 unit. This unit allows the facility to greatly expand existing efforts and bring advances in the study and treatment of novel cancer therapeutics to patients more quickly. Our Phase I unit is a regional center of excellence for patients to receive exciting new cancer treatment therapies.
For more information about clinical trials, call a member of Levine Cancer Institute Oncology Research Management Team at 980-442-2000.